1. Home
  2. TMDX vs PD Comparison

TMDX vs PD Comparison

Compare TMDX & PD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • PD
  • Stock Information
  • Founded
  • TMDX 1998
  • PD 2009
  • Country
  • TMDX United States
  • PD United States
  • Employees
  • TMDX N/A
  • PD N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PD Computer Software: Prepackaged Software
  • Sector
  • TMDX Health Care
  • PD Technology
  • Exchange
  • TMDX Nasdaq
  • PD Nasdaq
  • Market Cap
  • TMDX 2.1B
  • PD 1.7B
  • IPO Year
  • TMDX 2019
  • PD 2019
  • Fundamental
  • Price
  • TMDX $57.20
  • PD $18.29
  • Analyst Decision
  • TMDX Buy
  • PD Buy
  • Analyst Count
  • TMDX 11
  • PD 11
  • Target Price
  • TMDX $116.10
  • PD $22.09
  • AVG Volume (30 Days)
  • TMDX 2.6M
  • PD 1.1M
  • Earning Date
  • TMDX 02-24-2025
  • PD 03-13-2025
  • Dividend Yield
  • TMDX N/A
  • PD N/A
  • EPS Growth
  • TMDX N/A
  • PD N/A
  • EPS
  • TMDX 0.94
  • PD N/A
  • Revenue
  • TMDX $401,090,000.00
  • PD $457,170,000.00
  • Revenue This Year
  • TMDX $81.61
  • PD $11.41
  • Revenue Next Year
  • TMDX $22.52
  • PD $9.97
  • P/E Ratio
  • TMDX $61.04
  • PD N/A
  • Revenue Growth
  • TMDX 109.09
  • PD 8.71
  • 52 Week Low
  • TMDX $56.03
  • PD $16.46
  • 52 Week High
  • TMDX $177.37
  • PD $26.60
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 35.74
  • PD 45.60
  • Support Level
  • TMDX $58.40
  • PD $18.13
  • Resistance Level
  • TMDX $67.80
  • PD $19.00
  • Average True Range (ATR)
  • TMDX 4.59
  • PD 0.62
  • MACD
  • TMDX -0.27
  • PD 0.10
  • Stochastic Oscillator
  • TMDX 4.44
  • PD 64.32

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its platform harnesses digital signals from virtually any software-enabled system or device and combines it with human response data to take the right actions in real-time. The product offerings of the company include PagerDuty Incident Management, DevOps, AIOPs, Process Automation, and Customer Service Operations.

Share on Social Networks: